Senseonics Holdings Inc (SENS) reports impressive revenue growth and strategic advancements, despite facing challenges in ...

Q3 2025 Earnings Call Transcript November 5, 2025 Senseonics Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Fintel reports that on November 6, 2025, HC Wainwright & Co. maintained coverage of Senseonics Holdings (NYSEAM:SENS) with a ...

Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient ...

Senseonics (SENS) stock falls as the company posts strong Q3 growth but set its 2025 revenue outlook below consensus. Read ...

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share. The medical technology company ...

Germantown-based Senseonics Holdings Inc. (SENS) on Wednesday reported a loss of $19.5 million in its third quarter.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous ...

The company reported that 160% growth in new patient shipments over the prior-year period fueled the 90% year-over-year revenue growth. Direct-to-consumer (DTC) investments drove a 300% increase in ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

Arm Holdings doesn't sell chips; rather, it develops CPU architecture and intellectual property that it licenses. We believe Arm will remain the dominant architecture in smartphone CPUs, where it has ...